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Transgenic mouse modelJaagsiekte sheep retrovirus (JSRV) that causes contagious ovine pulmonary adenocarcinoma (OPA) in
sheep carries an oncogenic Envelope gene (Env), which is capable of transforming target cells in vitro and
in vivo. We cloned full-length JSRV Env cDNA into an expression vector, SPC/SV40, where the transgene
was driven by lung-speciﬁc surfactant protein C (SPC) promoter, to obtain SPC-JSRV Env construct. SPC-
JSRV Env was microinjected into immunocompetent FVB/N mice embryos to generate Env transgenic mice.
We obtained two lines of transgenic mice, both of which were capable of developing spontaneous lung
tumors from 1 month onwards and the tumor incidence rate was about 56% at the age of 7 months in Env
Transgenic line 1 and about 71% at the age of 6 months in Env Transgenic line 2. We were able to correlate
higher tumor incidence rate and tumorigenicity in Env Transgenic line 2 to higher level of expression of
Env transgene compared to Env Transgenic line 1. Immunohistochemical analysis showed that the tumor
was primarily composed of type II pneumocytes where SPC promoter is known to be active similar to
natural infection of JSRV in sheep. Analysis of cellular mitogenic signal transduction pathways revealed
signiﬁcant induction of p44/42 ERK pathway in the transgenic mice lungs with tumors compared to the
lungs from non-transgenic FVB/N mice. Tumors in our transgenic mice pose similarities to human lung
adenocarcinoma and therefore our mice could serve as a model system for evaluating the mechanisms of
lung tumorigenesis in vivo.
© 2009 Elsevier Inc. All rights reserved.Introduction
Jaagsiekte sheep retrovirus (JSRV) is a betaretrovirus that is known
to induce contagious pulmonary adenocarcinoma in sheep and goats
(Verwoerd et al., 1983). It is a simple retrovirus encoding Gag, Pro, Pol,
and Env proteins (DeMartini et al., 2001; Palmarini et al., 1999; York
et al., 1992) with no apparent known oncogene present in the
genome. However, expression of JSRV Env gene alone was found
capable of transforming target cells in culture (Maeda et al., 2001; Rai
et al., 2001) indicting Env to be an active oncogene.
JSRV Env is a type-I transmembrane protein having approxi-
mately 620 amino acids (DeMartini et al., 2001; Palmarini et al.,
1999; York et al., 1992), composed of a surface domain and
transmembrane domain that are linked by disulﬁde bonds and play
a role in mediating viral entry into cells by interacting with a
surface receptor (Liu and Miller, 2007). The cytoplasmic tail of JSRV
Env protein harbors an YXXM (Y is tyrosine, X can be any aminoR&D Center, National Health
nty 350, Taiwan, ROC.
.
l rights reserved.acid, M is methionine) motif, which is a putative binding site for the
phosphatidylinositol 3-kinase (PI3K) p85 regulatory subunit (Son-
gyang et al., 1993), which is essential for in vivo tumorigenesis by
JSRV (Cousens et al., 2007). Env-mediated in vitro transformation of
rodent cell lines, NIH 3T3 and 208F (Maeda et al., 2005), chicken
cells, CEF and DF-1 (Allen et al., 2002; Zavala et al., 2003) and
MDCK dog epithelial cells (Liu and Miller, 2005) was found to
induce PI3K/Akt pathway. Though PI3K was initially considered
essential for Env-mediated cellular transformation, further studies
indicated that PI3K was not required for JSRV-induced transforma-
tion (Chow et al., 2003; Maeda et al., 2003; Palmarini et al., 2001;
Zavala et al., 2003). However, in NIH3T3 mouse ﬁbroblasts and
RK3E rat epithelial cells, Env-mediated transformation induced
MAPK pathway (Maeda et al., 2005) highlighting its importance in
Env-mediated cell transformation. The exact mechanism of cellular
transformation induced by Env protein is still unknown, but is
supposed to be receptor-independent. Human Hyal2, but not mouse
Hyal2 is considered as a putative receptor for JSRV (Liu et al., 2003;
Rai et al., 2000; Rai et al., 2001). Other mouse proteins capable of
functionally interacting with Env are currently unknown.
Ovine pulmonary adenocarcinoma (OPA) tumors induced by JSRV
are of mixed phenotype, comprised of type II pneumocytes and Clara
cells of the lungs, predominantly the former cell type (Palmarini and
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tumors in sheep are found to resemble a subtype of human lung
adenocarcinoma (Mornex et al., 2003), a cancer found in non-
smokers. Over the years, attempts have been made to create small-
animal (mouse) models of JSRV Env-induced lung cancer instead of a
large-animal (sheep) model ((Dakessian et al., 2007; Wootton et al.,
2005) to study the mechanisms of Env-mediated cell transformation
in vivo.
Wootton et al. (2005) were able to induce lung tumors in immu-
nodeﬁcient mice by expressing JSRV Env protein using replication-
defective adeno-associated viral vector (AAV), which eventually
resulted in lethality. Dakessian et al. (2007) created mice transgenic
for JSRV Env expressed under SPA promoter in immunocompetent
Balb/c×C57Bl6J background. They were able to detect tumor
formation only in some founders and few F1 progeny.
In this paper, we have documented the induction of lung tumors
in JSRV Env transgenic mice in immunocompetent FVB/N back-
ground and the associated biochemical pathways. We have estab-
lished two stable lines of Env transgenic mice with targeted
transformation of type II pneumocytes of lung with a high incidence
of tumor formation, providing us with an adequate model system for
the study of lung cancer.
Results
Generation and screening of JSRV Envelope transgenic mice
A transducing vector, SPC/SV40, has been used in transgenic
mouse models to achieve high levels of transgene expression
restricted to pulmonary epithelial cells (Willett et al., 1998).
Surfactant protein C (SPC) promoter has been characterized to have
a unique lung tropism and is activated only in lung alveolar
epithelium. It has been used to drive lung-speciﬁc transgene expres-
sion in many transgenic animal models including SV40 large T antigen
(Wikenheiser and Whitsett, 1997), RON receptor tyrosine kinase
transgenic mice (Chen et al., 2002) and Notch3 transgenic mice
(Dang et al., 2003). In order to study JSRV Env-mediated
tumorigenesis in mice lungs, a full-length Env cDNA from JSRV
was cloned into SPC/SV40 vector between lung-speciﬁc SPC
promoter and SV40 poly A tail to create SPC-JSRV Env construct
(Fig. 1A). FVB/N mice embryos were microinjected with this
construct to generate Env transgenic mice. The founders were
then cross-mated with wild-type FVB/N mice to produce F1
progenies. Preliminary screening of F1 transgenic mice was carried
out by genomic PCR from tail DNA using primers speciﬁc to the
surface domain of envelope gene to amplify a 474 bp (252–725 bp)
region. Three mice that carried the Env transgene were identiﬁed
by genomic PCR – No. 8 (male, m), No. 9 (female, f) and No. 11 (f)
that carried the Env transgene (Fig. 1B) The F1 transgenic mice
were cross-mated to produce two lineages of F2 – No. 8×No. 9
(Env Tg line 1) and No. 8×No. 11 (Env Tg line 2).Fig. 1. Creation and screening of JSRV Env transgenic mice. A) JSRV envelope gene
construct for creation of transgenic mice. Envelope gene from JSRV was cloned under
lung-speciﬁc SPC promoter and SV40 poly A tail in the expression vector and used for
embryo microinjection. B) Genomic PCR of tail DNA of Env transgenic FVB/N F0 mice to
screen for the presence of Env transgene. Lanes 1–3: FVB/N mice, lanes 5–11: FVB/N F0
mice, lane 4: 1 kb ladder. Amplicon size was 474 bp.Incidence of lung tumors in Env transgenic mice
The two F2 transgenic lines were bred and maintained and mice
were sacriﬁced at periodic intervals and monitored for tumor
formation. Visible multifocal tumors, similar to those found in OPA
of JSRV-infected lambs, could be seen in the periphery of the lungs of
F2 transgenic mice from 1month onwards with increase in tumor size
with age while no tumor developed in FVB/N mice. The tumors
observed in 4-month-old mice were about 0.1–0. 2 cm in diameter, at
6 months they were 0.2–0.4 cm and at 8 months they were more than
0. 5 cm in diameter (Fig. 2A). The potency of developing larger tumors
was more in Env Transgenic line 2 mice than in Env Transgenic line 1
in similar age group. A comparison of the frequency of tumor
formation in the two lines of transgenic mice showed that Env Trans-
genic line 2 mice had increased tumor incidence rate compared to Env
Transgenic line 1 mice at each time point of examination. The
frequency of tumor formation at 6–7months agewas about 56% in Env
Transgenic line 1 (9/16), and 71% in Env Transgenic line 2 (10/14)
(Table 1). Based on the above observations, Env Transgenic line 1 was
found to be less tumorigenic than Env Transgenic line 2. In both the
transgenic lines no malignancy was observed in other organs or
tissues such as liver, spleen, intestines or thoracic muscle over a one
year follow up period. Tumor bearing lungs from both the Env
Transgenic lines were stained histochemically with hemotoxylin and
eosin to conﬁrm the presence of malignant tumor cells. While lungs
from FVB mice showed regular histology, the transgenic mice lungs
showed distinct development of adenocarcinoma (Fig. 2B). The tumor
was composed of neoplastic cells having multiple hyperchromatic
nucleoli and eosinophilic cytoplasm. It appeared to be surrounded by
areas of alveoli suggesting it to be a peripheral lung tumor involving
distal alveoli.
Tumors formed by type II pneumocytes of lungs
JSRV Env gene is sufﬁcient to induce lung tumors when expressed
in the lungs of newborn lambs (Caporale et al., 2006). Both naturally
occurring and experimentally induced OPA have been shown to
involve predominantly alveolar type II pneumocytes and Clara cells
(Platt et al., 2002). To corroborate these observations, we examined
the tissue type of malignant cells in the transgenic mice by immuno-
histochemical (IHC) staining using antibody speciﬁc to Clara cell
secretory protein (CCSP, a marker of Clara cells) (Fig. 3A) and anti-
body speciﬁc to proSPC (a marker of type II pneuomocytes) (Fig. 3B).
In the normal FVB/N mouse lung, immunostaining for CCSP was seen
in the bronchial lining, showing normal distribution of Clara cells
(panels a, d). Tumor lesions from 4-month-old mice of Env transgenic
line 1 or Env transgenic line 2 both showed no positivity for CCSP
marker (panels b, e and c, f respectively) suggesting that the tumor
was not constituted of Clara cells. In normal FVB/N lung, type II
pneumocytes showed a dispersed distribution (panels g, j). The tumor
cells from both the transgenic lines showed positive cytoplasmic
staining for proSPC (panels h, k and i, l), suggesting that the tumor
was composed of type II pneumocytes. In essence, lung tumor deve-
loped in the Env transgenic mice expressed proSPC but not CCSP,
implying that Env-mediated transformation indeed targeted type II
pneumocytes of the lungs leading to the development of lung tumors.
Expression level of Env in transgenic mice
In order to conﬁrm the expression of JSRV Env in the lungs of
transgenic mice, RT-PCR and IHC were performed. Tissue sections
were stained with anti-JSRV Env monoclonal antibody (B3+C9,
gifted by Dr. Miller) (Fig. 3C). While normal mouse lung had no
expression of Env protein (panels m, p), lung tumors from both the
transgenic lines showed distinct cytoplasmic staining for Env (panels
n, q and o, r), thereby conﬁrming transgene expression. Env expres-
sion was also detected in the non-tumor portion of the transgenic
mice lungs.
Fig. 2. Incidence of lung tumors in transgenic mice. (A) Lung tumors observed in Env transgenic mice at age of 4 months (b) 6 months (c) and 8months (d). Normal lung from FVB/N
mouse (a). (B) Histochemical staining with hemotoxylin and eosin to conﬁrm the presence of malignant tumor cells in Env Transgenic line 1 (b, d) and Env Transgenic line 2 (c, e)
mice compared to FVB/N normal lung tissue (a). Magniﬁcation 200× (a–c) and 400× (d, e).
122 E. Chitra et al. / Virology 393 (2009) 120–126Total RNA was extracted from the lung tissue of 4-month-old mice
and analyzed by RT-PCR using Env-speciﬁc primers to conﬁrm Env
gene expression. A PCR product corresponding to 474 bp was
obtained from both Env Transgenic line 1 (Nos. 1–6) and Env
Transgenic line 2 (Nos. 8–11) mice conﬁrming the expression of Env
transgene (Fig. 4A).Table 1
Incidence of tumors in two lines of Env transgenic mice.
Age
(months)
No. of mice with
lung tumors
Tumor incidence
rate (%)
Tumor in
other organs
Env Tg line 1 I 1/6 16.7 0/6
II 1/6 16.7 0/6
III 2/8 25 0/8
V 1/8 12.5 0/8
VII 9/16 56.3 0/16
Env Tg line 2 I 5/9 55.3 0/9
II 2/6 33.3 0/6
III 4/8 50 0/8
V 4/11 36.4 0/11
VI 10/14 71.4 0/14
Transgenic mice generated by embryo microinjection were back crossed with FVB/N
mice and by cross-mating of the F1 progeny, two stable transgenic lines namely Env
Transgenic line 1 and Env Transgenic line 2 were developed. Tumor incidence rate was
monitored in the two stable transgenic lines based on visible tumor formation. Other
organs observed for tumor formation were liver, spleen, intestines and thoracic muscle.Since Env Transgenic line 2 mice showed more malignancy in
terms of tumor incidence (Table 1) as well as tumor size, we wished
to quantitate Env gene expression levels in both the groups by
quantitative RT-PCR using primers to amplify a 61 bp region of Env
gene. Env Transgenic line 2 was found to have increased levels of
expression of Env gene with detectable signal observed after 22
cycles of PCR (blue line) while Env Transgenic line 1, on the other
hand, gave detectable signals only after 26 PCR cycles (Figs. 4B and
C). The approximate difference in cycling threshold (ΔCt) would be at
least 2, and therefore at least a four-fold increase in Env gene
expression is evident in Env Transgenic line 2 compared to Env
Transgenic line 1. Our results indicate that this increased expression
of Env could account for the increased malignancy observed in Env
Transgenic line 2.
Induction of MAPK and PI3K pathways in Env transgenic mice
MAPK and PI3K pathways have been indicted in Env-mediated
transformation of target cells in vitro (Allen et al., 2002; Maeda
et al., 2005; Zavala et al., 2003) as well as in vivo (Caporale et al.,
2006; Cousens et al., 2007; Maeda et al., 2005). This prompted us to
analyze the activation status of signaling pathways in the lungs of
transgenic mice. Cell lysates were prepared from the tumor bearing
lungs from Env Transgenic line 1 and Env Transgenic line 2 mice
and the phosphorylation pattern of the major signaling proteins,
Fig. 3. Tissue typing of tumor cells in the lung of transgenic mice by immunohistochemistry. Immunohistochemical analysis of sections of lung sections with (A) anti-Clara cell
secretory protein antibody speciﬁc for Clara cells and (B) anti-proSPC antibody speciﬁc for type II pneumocytes and (C) anti-Env antibody speciﬁc for JSRV envelope protein in FVB/N
(a, d, g, j, m and p), Env Transgenic line 1 (b, e, h, k, n and q) and Env Transgenic line 2 (c, f, i, l, o and r) mice. Magniﬁcation 200× for top panel (a–c, g–i, m–o) and 400× for bottom
panels (d–f, j–l, p–r).
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the immunoblot analyses that p44/42 ERK was strongly phospho-
rylated in all the Env transgenic mice compared to normal FVB/N
mice. Phosphorylation of p38 MAPK was induced in 3 mice from
Env Transgenic line 1 and one mouse from Env Transgenic line 2
compared to FVB/N control mice. Analysis of phosphorylation status
of Akt at Ser473 and Thr308, the residues involved in Akt activation
(Alessi et al., 1996) revealed that while there was no change in
phosphorylation at Thr308 of Akt, only two mice showed increased
phosphorylation at Ser473 in the transgenic mice compared to
normal mice (Fig. 5). This suggests that Akt pathway is not speci-
ﬁcally activated above normal levels by Env transgene expression in
the lungs. These data indicate that in our transgenic mice, ERK
pathway seems to play a signiﬁcant role in tumorigenesis.Discussion
The present study describes the creation and characterization of
JSRV Env transgenic mice in immunocompetent FVB/N background
under lung-speciﬁc SPC promoter. We have observed spontaneous
induction of lung tumors from 1 month of age onwards in our
transgenic mice, with a progressive increase in tumor incidence and
tumor size with age. We have conﬁrmed Env gene expression in
the lungs by RT-PCR and by immunohistochemistry using anti-Env
monoclonal antibody. Tumor formation was monitored for over one
year in the transgenic animals. A variable extent of metastasis of
JSRV-induced lung tumors in sheep has been reported (De las Heras
et al., 2003), but we did not observe any metastasis in our trans-
genic mice (Table 1).
Fig. 4. Expression analysis of Env gene in transgenic mice. (A) RT-PCR analysis of RNA
extracted from lung tissues of Env transgenic and normal FVB/N mice to check for
the expression of Env transgene. Results shown for Env Transgenic line 1 (lanes 1–6),
Env Transgenic line 2 mice (lanes 8–11), FVB/N mice (lane 12) and 1 kb ladder (lane 7).
Amplicon size: 474 bp. (B) Quantitative RT-PCR analysis of RNA extracted from transgenic
mice lungs to quantify Env gene expression levels in Env Transgenic line 1 (red lines) and
Env Transgenic line 2 (blue lines) mice compared to Env gene carrying plasmid DNA as
standard (pink lines). The average numbers of PCR cycles needed for ﬂuorescent detection
of Env gene are represented in the plot. (C) Schematic representation of the average PCR
cycle threshold fordetection ofEnv genebyquantitative RT-PCR fromEnvTransgenic line1
and line 2 mice lungs. (⁎P=0.019).
Fig. 5. Western blot analysis to detect signaling pathways induced in transgenic mice.
Lysates were prepared by homogenization of lung tissue excised from the two lines of
transgenic mice and normal FVB/N mice. Results show levels of phospho p44/42 ERK,
p44/42 ERK, phospho p38 MAPK, p38 MAPK, phospho Ser473 Akt, phospho Thr308 Akt
and Akt in Env Transgenic line 1 (lanes 1–4) and Env Transgenic line 2 (lanes 7–10)
mice and FVB/N (lanes 5,6) mice.
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of Env gene expression as determined by quantitative RT-PCR (Fig. 4).
Higher tumor incidence rate observed in Env Transgenic line 2 could
be correlated to higher expression levels of the Env transgene as
compared to Env Transgenic line 1. It is a notable ﬁnding that expres-
sion levels of Env play a role in the extent of cellular transformation
and malignancy induced in transgenic animals.
Expression of Env was found restricted to type II pneumocytes of
lung tissue (proSPC +ve, Env +ve and CCSP −ve), attributed to the
use of SPC promoter speciﬁc for this cell type. Surfactant protein C is a
component of pulmonary surfactant of the lung; it is active in type II
pneumocytes and is expressed in 80% of the tumor cells of JSRV-
induced OPA (Platt et al., 2002). Tumor cells of both OPA and human
lung adenocarcinoma express markers of type II pneumocytes and
Clara cells. JSRV is unique among retroviruses in being able to
transform these cell types. The long terminal repeats (LTR) promoter
and enhancer of JSRV exhibit transcriptional speciﬁcity for secretory
lung epithelial cells (Dakessian and Fan, 2008; Palmarini et al., 2000).Earlier, lung tumors primarily composed of type II pneumocytes
were induced in immunodeﬁcient mice by expressing Env gene
using adeno-associated virus (AAV) vector (Wootton et al., 2005),
but ultimately the mice succumbed owing to lethality. Yet,
expression of Env gene in immunocompetent mice using AAV was
not successful and tumor development was blocked.
Recently, immunocompetent Env transgenic mice expressing Env
gene under surfactant protein A (SPA) promoter were created but
they developed only subdermal lipomas with low tumor incidence
rate and low efﬁciency of transgene expression in the lung
(Dakessian et al., 2007). Though they had initially selected SPC
promoter for creation of Env transgenic mice, after failed trans-
plants of microinjected embryos, they switched to using SPA
promoter to express Env gene with HA tag. They claim that HA
tag reduced the transforming potency of Env, which might explain
the low tumor incidence rate. They conclude that since SPA pro-
moter responds to the transcription factor C/EBPα that is found in
abundance in adipocytes and lung epithelial cells this might have
induced the lipomas.
While we did not observe any lethality using SPC promoter, we
could achieve speciﬁc expression of Env in type II pneumocytes of
our transgenic mice lungs resulting in spontaneous induction of
multifocal lung tumors from the age of 1 month onwards. Dakessian
et al., (2007) used a mixed background of mice parentage (Balb/
c×C57/Bl6J) for injection of the transgene and crossed it with FVB/N
mice to generate the F1s. We have used FVB/N mice for introduction
of transgene; these mice are known to have higher tumor incidence
rates and are ideal for microinjection and creation of transgenic mice
(Mahler et al., 1996). Our successful creation of JSRV Env transgenic
mice might be attributed to the choice of the promoter, mouse
background and use of Env gene per se without any tag, which has
enabled us to breed and maintain these animals for over 1 year.
Another notable contribution of our model is that we created two
transgenic lines with variable levels of Env expression allowing us to
assess Env dose-dependent effect on tumorigenesis.
Immunohistochemical staining of tumor tissues from experimen-
tal and natural OPA showed strong activation of Raf, MEK and ERK
(Caporale et al., 2006; De Las Heras et al., 2006; Maeda et al., 2005)
and pharmacological inhibitors for Ras and MEK completely inhibited
transformation of NIH 3T3 ﬁbroblasts in vitro (Maeda et al., 2005)
conﬁrming the major role of MEK–ERK signaling pathway in Env-
induced transformation of target cells. However, Akt phosphorylation
was not observed by immunohistochemical staining of lung tumor
sections of naturally occurring OPA in sheep (Zavala et al., 2003) and
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mouse ﬁbroblast cells in vitro (Maeda et al., 2003). Corroborating
these ﬁndings, our transgenic mice also show a strong induction of
ERK phosphorylation without any signiﬁcant change in phosphory-
lation status of Akt. MAPK (p38) is reported to be constitutively
activated in transformed cells in vitro but in vivo, not all tumors
showed activation of p38 MAPK (Maeda et al., 2005) similar to what
we have observed in our transgenic mice. Our observations indicate a
greater role for p44/42 ERK pathway in Env-mediated tumor
formation in vivo.
The generation of transgenic mice carrying Env oncogene is
valuable in determining the effects of this gene upon tumor develop-
ment and oncogenesis. Our results indicate that JSRV Env gene under
SPC promoter achieves targeted transformation of type II pneumo-
cytes leading to the induction of lung tumors in our transgenic mice. It
has been recorded that OPA caused by natural infection of JSRV and
human lung adenocarcinoma share many similarities in clinical and
histological features (Rosenberg, 2001) and therefore transgenic mice
with Env-induced lung tumors have the potential to serve as animal
models for human lung cancer. Thismousemodel can be used to study
the molecular mechanisms of oncogenic transformation, for assessing
the potential carcinogenic risk of environmental agents and for
screening anti-cancer agents.
Materials and methods
Cloning of JSRV envelope gene in expression vector
Jaagsiekte sheep retrovirus (JSRV) envelope gene (Genbank
Accession No. AF105220) (gifted by Hung Fan, University of California,
Irvine, USA) was ampliﬁed by PCR and inserted into the SPC/SV40
vector (Li et al., 2002; Willett et al., 1998) at the multiple cloning site
using SalI and HindIII to obtain SPC-JSRV Env construct. The primers
used to amplify the 1845 bp envelope gene were: 5′-TTCCCATGGA-
TGCCGAAGCGCC GCG CT-3′ as forward primer paired to 5′-CTTA-
AGCTTTCACGGGTCGTCCCCCGCA TC-3′ as reverse primer. The
conditions used for the PCR run were: 94 °C for 5 min; followed by
30 cycles of 94 °C for 45 s, 60 °C for 45 s and 72 °C for 90 s; followed by
incubation at 72 °C for 7 min. The encoding sequences in the SPC-JSRV
Env plasmid were conﬁrmed by DNA sequencing.
Creation and maintenance of JSRV Env transgenic mice
JSRV Env transgenic animals were generated by microinjection of
1.0 ng of linear SPC-JSRV Env construct into fertilized FVB/N mouse
embryos at a single cell stage, which were subsequently implanted
into pseudo pregnant FVB/N female mice, generating transgenic
animal following the protocol described previously (Brinster et al.,
1985). FVB/N mice were purchased from the National Applied
Research Laboratories – Laboratory Animal Center, Taiwan. SPC-JSRV
Env plasmids were linearized with the restriction enzyme HindIII and
recovered from agarose gels (Thermo Fisher Scientiﬁc, IL, USA) with
gel extraction kit (Qiagen, Germany). Transgenic lineages were
maintained by cross-mating of Env transgenic individuals to obtain
Env transgenic FVB/N F1 inbred mice. Mice were maintained in
accordance with the institutional animal use protocol.
Genotyping and the detection of envelope gene expression
Genomic DNA was extracted from transgenic mice tails with
Tissue & Cell genomic DNA puriﬁcation kit (GeneMark, Taiwan
ROC). Env transgene was detected in genomic DNA by PCR to
amplify a 474 bp region (252–725 bp) using the following primers:
forward: 5′-GCG TACATTCCTGATCCGCCAATG-3′ and reverse: 5′-
CGGATGCTGT CCTCGATATTCAGG-3′. The conditions used for the
PCR run were: 94 °C for 5 min; followed by 30 cycles of 94 °C for45 s, 55 °C for 45 s, and 72 °C for 45 s; followed by incubation at
72 °C for 7 min. Amplicon size was 473 bp.
Total RNA was isolated from Env transgenic mice lungs with
tumors as well as from normal mice. RNA was isolated from mice
lungs using TRIZOL reagent (Invitrogen, CA, USA) following the
manufacturer's instructions. Purity of the isolated RNA was evaluated
spectrophotometrically by the A260/A280 absorbance ratio. Two
micrograms of total RNA was used for reverse transcription
polymerase chain reaction (RT-PCR) to amplify the mRNA of Env
gene using one-step RT-PCR Premix reagent (iNtRON Biotechnology,
Korea). The primers used were the same as in genomic PCR reaction,
with same amplicon size. Program of RT-PCR reaction was set at
45 °C for 30 min, 94 °C for 5 min; followed by 35 cycles of 94 °C for
1 min, 55 °C for 1 min and 72 °C for 1 min; followed by incubation at
72 °C for 7 min for ampliﬁcation of Env gene.
Quantiﬁcation of Env gene expression
Expression levels of Env mRNA in lung tumors from transgenic
micewere assessed by quantitative PCR analysis (The LightCycler® 480
Real-Time PCR system) with Env speciﬁc primer pairs, forward: 5′-
CGAGTGACTATCTCAGGCATTG-3′ (481–502 bp) and reverse: 5′-
TAGTATGCCCTTGCCTAGAC-3′ (522–541 bp) and probe set No. 48:
ACTGGGAA (Cat. No. 04688082001) from Roche Universal Probe
Library Assay Design Center (Roche, Switzerland). The plasmid
carrying Env gene was used as a standard at different concentrations
(5, 0.5 and 0.05 pg /ml). The number of cycles needed for the
ampliﬁcation of Env gene from the two lineages of transgenicmicewas
compared. Statistical analysis was done by unpaired Student's t test.
Histochemistry and immunostaining
Whole lungs were excised from the mice, ﬁxed in 10% formalin
(Sigma-Aldrich, USA) solution overnight and embedded in parafﬁn
(Thermo Fisher Scientiﬁc, IL, USA) for sectioning. The sections were
processed and stained with 1% hematoxylin and eosin solution
(Sigma-Aldrich, USA). For immunohistochemistry, the sections were
stained with rabbit polyclonal anti-Clara cell secretory protein (CCSP)
antibody (1:200 dilution, Millipore, CA, USA) or rabbit polyclonal anti-
prosurfactant protein C antibody (1:400 dilution, Millipore, CA, USA)
or mouse monoclonal anti-Env antibody (1:50 dilution, a gift from Dr.
Dusty Miller, Fred Hutchinson Cancer Research Center, USA) followed
by the appropriate secondary antibodies. Bright ﬁeld microscopy
pictures were taken at 200× and 400× magniﬁcations.
Western blot analysis
Tumor bearing lung tissues from 7-month-old mice were cut to
pieces and ground in ice-cold lysis buffer (50 mM Tris–HCl, 150 mM
NaCl, 1% Triton X-100 and 1× protease inhibitor cocktail (Roche,
Switzerland)) to prepare cell lysate. Cell debris was removed by
centrifugation at 14,000 ×g for 20 min at 4 °C. The proteins were
separated by SDS-PAGE and transferred onto Hybond ECL nitrocel-
lulose membrane (GE healthcare, UK) and probed with polyclonal
antisera raised against p44/42 MAPK, phospho p44/42 MAPK Thr202/
Tyr204, Akt, phospho Akt Ser473, phospho Akt Thr308 (Cell Signaling
Technology, USA) followed by anti-rabbit and anti-mouse secondary
antibodies conjugated to HRP (Thermo Fisher Scientiﬁc, IL, USA) and
detected by ECL using SuperSignal West Pico chemiluminescent
substrate (Thermo Fisher Scientiﬁc, IL, USA).
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